Advise patients to establish a routine pattern with regard to meals. The recommended starting dose of Methylphenidate Hydrochloride Extended-Release Capsules for patients 6 years and older is 10 mg once daily in the morning with or without food. Maintain careful prescription records, educate patients about abuse, monitor for signs of abuse and overdose, and periodically re-evaluate the need for Methylphenidate Hydrochloride Extended-Release Capsules use.
Īssess the risk of abuse prior to prescribing, and monitor for signs of abuse and dependence while on therapy. Prior to treating pediatric patients and adults with CNS stimulants including Methylphenidate Hydrochloride Extended-Release Capsules, assess for the presence of cardiac disease (i.e., perform a careful history, family history of sudden death or ventricular arrhythmia, and physical exam). Methylphenidate ER Capsules Dosage and Administration Pretreatment Screening Pediatric patients younger than 6 years of age experienced higher plasma exposure than patients 6 years and older at the same dose and high rates of adverse reactions, most notably weight loss. Methylphenidate Hydrochloride Extended-Release Capsules is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD ) in patients 6 years and older. Indications and Usage for Methylphenidate ER Capsules Assess the risk of abuse prior to prescribing, and monitor for signs of abuse and dependence while on therapy. CNS stimulants, including Methylphenidate Hydrochloride Extended-Release Capsules, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence.
0 kommentar(er)
